CKD: Clinical Trials

2 trials for CKD, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 2

Follow CKD: new trials by email Literature Review of CKD trials Research Report on CKD

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial
Empagliflozin 10 MG, Finerenone, Withings BPM Connect - Diabetes Mellitus Type 2 With Proteinuria, Diabetes Mellitus, Type 2
Phase 4CompletedUniversity Medical Center Groningen122024-07-292026-02-13
Decentralized N=1 Study: A Feasible Approach to Evaluate Individual Therapy Response to Dapagliflozin.
Dapagliflozin 10mg Tab, Placebo, Withings BPM Connect - Diabetes Mellitus, Type 2, Diabetes Mellitus Type 2 With Proteinuria
Phase 4CompletedUniversity Medical Center Groningen202021-05-112024-04-22

Narrower conditions

Albuminuria (2)  ·  Diabetes Complications (2)  ·  Diabetes Mellitus (2)  ·  Diabetes Mellitus, Type 2 (2)  ·  Renal Insufficiency, Chronic (2)  ·  Proteinuria (1)

Broader conditions

Chronic Disease (2)  ·  Disease Attributes (2)  ·  Endocrine System Diseases (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Glucose Metabolism Disorders (2)  ·  Kidney Diseases (2)  ·  Male Urogenital Diseases (2)  ·  Metabolic Diseases (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Renal Insufficiency (2)  ·  Signs and Symptoms (2)  ·  Urination Disorders (2)

Interventions

Digital Technology (1)  ·  Micro-Electrical-Mechanical Systems (1)  ·  dapagliflozin (1)  ·  empagliflozin (1)  ·  finerenone (1)

Sponsors

University Medical Center Groningen (2)

Countries

Netherlands (2)

Top investigators

Hiddo Lambers Heerspink (1)

Results publications

PMID 42530392